Clinical Trial Update: Efficacy and Safety of Encapsulated Bifidobacterium Longum BBH016 in Subjects With Lower Gastrointestinal Symptoms [NA]

View source ↗

Summary

A clinical trial evaluating the efficacy and safety of encapsulated Bifidobacterium longum BBH016 in subjects with lower gastrointestinal symptoms, including ir…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diarrhea
• Irritable Bowel Syndrome

Drugs mentioned

• Encapsulated Bifidobacterium longum BBH016 (Bifidobacterium longum BBH016)

Snippet

Sponsor: Seoul National University Bundang Hospital | Conditions: Lower Abdominal Pain, Diarrhea | NA | Status: ACTIVE_NOT_RECRUITING